Autosomal Dominant Tubulointerstitial Kidney Disease Case with Sever Acute Kidney Injury in Activities Beyond the Usual: An Unusual Presentation of the Disease


avatar Fereshteh Saddadi ORCID 1 , avatar Fateme Elahi ORCID 1 , * , avatar Azin Ghaffari ORCID 2

Department of Nephrology, Hasheminejad Kidney Center, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran
Rajaie Cardiovascular Medical and Research Center, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran

how to cite: Saddadi F, Elahi F, Ghaffari A. Autosomal Dominant Tubulointerstitial Kidney Disease Case with Sever Acute Kidney Injury in Activities Beyond the Usual: An Unusual Presentation of the Disease. J Health Rep Technol. 2024;10(1):e143852.



Autosomal dominant tubulointerstitial kidney disease (ADTKD) is associated with multiple gene mutations and is recognized under various names, including medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, uromodulin-associated kidney disease, and medullary cystic kidney disease type 2. A comprehensive understanding of these rare disorders can shed light on the pattern of tubulointerstitial fibrosis observed in various forms of chronic kidney disease.

Case Presentation:

Here, a case of a patient is presented who experienced acute kidney injury (AKI) following severe physical activity and an atypical manifestation of this genetic disorder. Typically, ADTKD leads to a gradual loss of kidney function, but the patient presented with AKI. The patient's renal function returned to normal following appropriate therapy. The patient's brother had a similar history of renal disease following physical activities, prompting suspicion of a shared genetic disorder.


A genome-wide association study (GWAS) was conducted, and the results revealed the presence of the mucin 1 (MUC1) mutation, confirming the diagnosis of ADTKD. This case highlights the importance of recognizing atypical presentations of genetic disorders and utilizing advanced genetic studies for accurate diagnosis and management.

1. Introduction

Autosomal dominant tubulointerstitial kidney disease (ADTKD) is an inherited renal disorder characterized by progressive renal insufficiency, tubulointerstitial nephropathy, and normal urinary sediment (1). Various gene mutations associated have been identified with ADTKD, including uromodulin, renin, mucin-1 (MUC-1), hepatocyte nuclear factor 1β, and SEC61A1 mutations (1-3), which affect the coding of proteins crucial for normal renal function. The clinical presentation of ADTKD is nonspecific and depends on the specific gene mutation (4). Patients with MUC-1 mutations universally progress to chronic kidney disease (CKD) stage (1). The MUC-1 gene is situated on chromosome 1q21, and mutations result from cytosine duplication, leading to a frameshift mutation. The accumulation of abnormal proteins in renal tubular cells is a critical pathogenic factor (1).

Diagnostic criteria for ADTKD include hereditary CKD with an autosomal dominant pattern, affecting clinical and histological features in at least one relative. A definitive diagnosis may not be solely established through kidney biopsy. Alternatively, confirmation of one of the four mutations in the patient or at least one family member is indicative of ADTKD (5).

2. Case Presentation

A 42-year-old police officer participated in swimming competitions for the first time two years ago. Two days after the event, he experienced muscle pain and noticed red urine, and his serum creatinine level was elevated at 3 mg/dL. Then, he was treated with hydration and conservative management, decreasing serum creatinine to 0.8 mg/dL.

Six months later, he engaged in a high-stakes situation involving criminals and traveled a long distance. The following day, he felt unwell and sought intravenous fluid treatment. Several months after this incident, he was admitted to the hospital for a similar incident, and his symptoms included red urine, muscle pain, and decreased urine volume.

The serum creatinine level was 10 mg/dL, while creatine phosphokinase (CPK) and serum electrolytes were within normal ranges. The patient had no history of alcohol intake, tobacco consumption, or drug abuse. Similar symptoms were reported by his 40-year-old brother, a police officer, who experienced red urine and muscle weakness related to work activities. However, his brother's maximum creatinine rise was only 3mg/dL, and his physical examination was unremarkable.

On the first day, blood test results were as follows: Hemoglobin 16.7 g/dL; blood urea 72 mg/dL, serum creatinine 10 mg/dL, serum uric acid 1.8 mg/dL, serum sodium 138 meq/L, serum potassium 4.9 meq/L, serum phosphate 5.5 meq/L, serum calcium 10.5 meq/L, and serum CPK 94 mg/dL. Urinary sediment revealed 3 - 4 RBCs in a high-power field without proteinuria. HIV, HCV, and HBV tests were negative, and hemolytic and rheumatologic assessments were within normal limits. Renal sonogram results were normal, and a biopsy was not performed based on the patient's preference.

Four sessions of hemodialysis were conducted based on his uremic symptoms. When discharging, his blood test results were as follows: Hemoglobin 13.2 g/dL, blood urea 34 mg/dL, serum creatinine 1.2 mg/dL, and electrolyte levels were within the normal range.

In the genetic analysis, no findings indicated myopathy in either nuclear or mitochondrial forms. The patient DNA sample revealed a homozygous mutation (158340) in the MUC-1 gene on chromosome 1q22 (Table 1).

Table 1.

Next Generation Sequencing-Based Analysis Method (WES200X)

GeneA.A. Change, HGVSMIM-Phenotype
p. Thr544A1a
SLC2A9NM-001001290Hereditary renal hypouricemia type 2

In the follow-up six months later, he reported being in good overall condition with no symptoms during a phone call, even though he had changed his position within the police office.

3. Discussion

A middle-aged man was presented with acute kidney injury (AKI), diagnosed with ADTKD related to MUC-1, exhibiting a positive response to fluid therapy and temporary hemodialysis. The characteristic symptoms of ADTKD related to MUC-1 included an absence of proteinuria or hematuria. The elevation in serum creatinine typically began in middle age and gradually progressed (4, 6). The glomerular filtration rate (GFR) decreases by 10 mL/min per year, leading to the development of CKD in the fifth decade (4, 6-8). In this case, the patient experienced AKI episodes and hematuria, which are not typical symptoms of MUC-1 (9, 10). Mucin-1 patients usually do not present with gout, anemia, or other extra-renal symptoms, confirmed as a pattern in the studies' patients.

Autosomal dominant tubulointerstitial kidney disease is an autosomal dominant inherited disorder, carrying a 50% chance of transmission to the next generation from each affected parent (2). Unfortunately, information on the kidney status of both parents is unavailable due to their demise in previous years. The recommended treatment for ADTKD related to MUC-1 involves a lifestyle modification program, including routine daily mild exercise, avoidance of obesity and smoking, and optimal control of hypertension, dyslipidemia, and hyperglycemia. A kidney transplant is a therapeutic option (5).

In conclusion, ADTKD is a rare disorder with limited information available. Any patient with an unexplained increase in creatinine, whether acute or chronic, should be considered for this test.


  • 1.

    Wang GQ, Rui HL, Dong HR, Sun LJ, Yang M, Wang YY, et al. SMRT sequencing revealed to be an effective method for ADTKD-MUC1 diagnosis through follow-up analysis of a Chinese family. Sci Rep. 2020;10(1):8616. [PubMed ID: 32451462]. [PubMed Central ID: PMC7248079].

  • 2.

    Kirby A, Gnirke A, Jaffe DB, Baresova V, Pochet N, Blumenstiel B, et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet. 2013;45(3):299-303. [PubMed ID: 23396133]. [PubMed Central ID: PMC3901305].

  • 3.

    Cormican S, Connaughton DM, Kennedy C, Murray S, Zivna M, Kmoch S, et al. Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland. Ren Fail. 2019;41(1):832-41. [PubMed ID: 31509055]. [PubMed Central ID: PMC6746258].

  • 4.

    Faguer S, Decramer S, Chassaing N, Bellanne-Chantelot C, Calvas P, Beaufils S, et al. Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. Kidney Int. 2011;80(7):768-76. [PubMed ID: 21775974].

  • 5.

    Bleyer AJ, Kidd K, Zivna M, Kmoch S. Autosomal Dominant Tubulointerstitial Kidney Disease. Adv Chronic Kidney Dis. 2017;24(2):86-93. [PubMed ID: 28284384]. [PubMed Central ID: PMC5488707].

  • 6.

    Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, et al. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers. 2019;5(1):60. [PubMed ID: 31488840].

  • 7.

    Moskowitz JL, Piret SE, Lhotta K, Kitzler TM, Tashman AP, Velez E, et al. Association between genotype and phenotype in uromodulin-associated kidney disease. Clin J Am Soc Nephrol. 2013;8(8):1349-57. [PubMed ID: 23723338]. [PubMed Central ID: PMC3731914].

  • 8.

    Bollee G, Dahan K, Flamant M, Moriniere V, Pawtowski A, Heidet L, et al. Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. Clin J Am Soc Nephrol. 2011;6(10):2429-38. [PubMed ID: 21868615]. [PubMed Central ID: PMC3359549].

  • 9.

    Ayasreh N, Bullich G, Miquel R, Furlano M, Ruiz P, Lorente L, et al. Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1. Am J Kidney Dis. 2018;72(3):411-8. [PubMed ID: 29784615].

  • 10.

    Bleyer AJ, Kmoch S. Autosomal dominant tubulointerstitial kidney disease: of names and genes. Kidney Int. 2014;86(3):459-61. [PubMed ID: 25168494].